Mohamed bouattour

Head of Unit

France

Research Interests

Explore related searches

Professors in France Professors in Medical Imaging Medical Imaging professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Mohamed Bouattour is the Head of Unit at Hôpital Beaujon in France. His research focuses on advanced liver cancers, with recent publications covering topics such as the efficacy of Sunitinib and pembrolizumab in treatment regimens, diagnostic biomarkers for hepatocellular carcinoma, and multidisciplinary approaches to liver tumor imaging and treatment. He has contributed significantly to studies evaluating innovative therapies for cholangiocarcinoma and hepatocellular carcinoma.

Articles (15)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Collaborators (10)

Carlos Moctezuma-Velazquez

Assistant Professor

University of Alberta

CANADA

View details

Tobias Meischl

Medical University of Vienna

AUSTRIA

View details

Alejandro Forner

SPAIN

View details

Emmanuel Deshayes

University of Montpellier

FRANCE

View details

Helen Reeves

Professor of Liver Cancer

Newcastle University

UNITED KINGDOM

View details

José Ríos

Universitat Autònoma de Barcelona (UAB)

SPAIN

View details

Lorenz Balcar

Medical University of Vienna

AUSTRIA

View details

Michael Trauner

Professor of Medicine and Chair of Gastroenterology and Hepatology

Medical University of Vienna

AUSTRIA

View details

Jérémy Dana

FRANCE

View details

Thomas Reiberger

Medical University of Vienna

AUSTRIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mohamed bouattour

Research Interests

Explore related searches

Contact this professor

About

Articles (15)

Sunitinib as Second‐Line Treatment in Advanced Intrahepatic Cholangiocarcinoma: Results From the SUN‐CK GERCOR Phase II Trial

PSMA immunohistochemistry as a diagnostic biomarker of hepatocellular carcinoma

Regorafenib plus modified gemcitabine-oxaliplatin in patients with advanced biliary tract cancer. The randomized phase Ib/II BREGO study

Second-line pembrolizumab for advanced HCC: Meta-analysis of the phase III KEYNOTE-240 and KEYNOTE-394 studies

ESR Bridges: imaging and treatment of uncommon liver tumours—a multidisciplinary view

Evolution of liver function during immune checkpoint inhibitor treatment for hepatocellular carcinoma

Atezolizumab and bevacizumab for non‐resectable or metastatic combined hepatocellular‐cholangiocarcinoma: A multicentric retrospective study

ESR Bridges: imaging and treatment of hepatocellular carcinoma—a multidisciplinary view

Pemigatinib for patients with previously treated, locally advanced or metastatic cholangiocarcinoma harboring FGFR2 fusions or rearrangements: A joint analysis of the French PEMI-BIL and Italian PEMI-REAL cohort studies

Efficacy of transarterial radioembolization using Y-90 resin microspheres versus atezolizumab-bevacizumab in unresectable hepatocellular carcinoma: A matching-adjusted indirect comparison

Transversal psoas muscle thickness measurement is associated with response and survival in patients with HCC undergoing immunotherapy

Improving pain control during transarterial chemoembolization for hepatocellular carcinoma performed under local anesthesia with multimodal analgesia

The Safety and Effectiveness of Hepatic Transarterial Embolic Locoregional Therapy in Patients with Contraindications to Hepatectomy after Portal Vein Embolization

Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study.

Enhancing capsule in hepatocellular carcinoma: intra-individual comparison between CT and MRI with extracellular contrast agent

Collaborators (10)

Carlos Moctezuma-Velazquez

Tobias Meischl

Alejandro Forner

Emmanuel Deshayes

Helen Reeves

José Ríos

Lorenz Balcar

Michael Trauner

Jérémy Dana

Thomas Reiberger

Make your next move.